# Safety, Tolerability, and Preliminary Effectiveness of CTH120 in Fragile X Syndrome

> clinical trial · VERIFIED · 2026-07-17

Status: RECRUITING · Sponsor: Connecta Therapeutics, S.L. · Condition: Fragile X Syndrome (FXS)

- Company: Connecta Therapeutics, S.L.
- Sector: Fragile X Syndrome (FXS)
- Primary source: https://clinicaltrials.gov/study/NCT07654114

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.